A case series evaluating the serological response of adult asthma patients to the 23-valent pneumococcal polysaccharide vaccine

BACKGROUND: Asthma is an independent risk factor for invasive pneumococcal disease; however, the immune response of adult asthma patients to pneumococcal vaccination is unknown. We explore the serologic response of patients with moderate to severe asthma to the 23-valent pneumococcal polysaccharide...

Descripción completa

Detalles Bibliográficos
Autores principales: Laratta, C. R., Williams, K., Vethanayagam, D., Ulanova, M., Vliagoftis, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463404/
https://www.ncbi.nlm.nih.gov/pubmed/28596792
http://dx.doi.org/10.1186/s13223-017-0200-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463404/
https://www.ncbi.nlm.nih.gov/pubmed/28596792
http://dx.doi.org/10.1186/s13223-017-0200-2

Ejemplares similares